Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $362.50-$533.67 |
Market Cap | $123.1B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $12.2B |
Revenue Growth (YoY) | 7.8% |
Gross Profit (12 Mos) | $6.6B |
Diluted EPS | $16.84 |
News
See moreYahoo Finance • 2 hours ago
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
Yahoo Finance • 16 hours ago
Vortex Energy Corp. Announces Closing of LIFE Offering
Yahoo Finance • 22 hours ago
Neos Nasdaq-100 High Income ETF Experiences Big Inflow
Yahoo Finance • 2 days ago
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,400 |